Safe Harbor Financial expects significant benefits from the recent DOJ order moving medical marijuana to Schedule III, effective April 22, 2026. The removal of the 280E tax burden is projected to enhance operator financial health, increase banking activity, and expand Safe Harbor's addressable market, positioning the company for potential growth in the regulated cannabis sector.
The restructuring of federal policy is expected to materially enhance Safe Harbor's revenue and operational viability, similar to positive reactions seen previously with regulatory shifts in other sectors.
Buy SHFS as tax relief and market expansion are likely to boost revenue in 2026.
This update fits under 'Corporate Developments,' as it represents a landmark shift in cannabis regulation that may significantly affect Safe Harbor's business model and market prospects. The evolving legislative environment is critical for investors to monitor, especially within the cannabis sector.